STEVENS CAPITAL MANAGEMENT LP

Position in NVO — Novo Nordisk A S

CIK 1134813 RADNOR, PA

Position in NVO

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$640,622

-$6,405,676 QoQ

Shares Held

13,363

-93.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#639

of 1,348 holders

Holding Since

Jun 2020

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

STEVENS CAPITAL MANAGEMENT LP holds $7,554,742 across 5 Drug Manufacturers - General names. NVO ranks #5 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,749	$3,297,233
2	PFE	Pfizer Inc	85,193	$2,051,447
3	GILD	Gilead Sciences, Inc.	6,346	$801,753
4	JNJ	Johnson & Johnson	3,007	$763,687
5	NVO	Novo Nordisk A S This page	13,363	$640,622

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$640,622	13,363	-93.0%	Shares	Sole	2026-08-11
2026-03-31	$7,046,298	191,736	+2035.4%	Shares	Sole	2026-05-11
2020-06-30	$587,944	8,979	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.